Akebia Therapeutics, Inc.
AKBA
Revenue
57.34M
▲10.84M▲23.31%
3 Months ChangeAssets
310.19M
▲89.52M▲40.57%
3 Months ChangeLiabilities
285.60M
▲15.75M▲5.84%
3 Months ChangeFree Cash Flow
-13.61M
▲5.83M▲29.99%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-22
Form 8-K
ID: 0001517022-24-000070
2024-10-16
Form 8-K
ID: 0001517022-24-000067
2024-08-08
Form 10-Q
ID: 0001628280-24-035879
2024-08-08
Form 8-K
ID: 0001517022-24-000065
2024-07-11
Form 8-K
ID: 0001517022-24-000061
2024-06-24
Form 8-K
ID: 0001517022-24-000059
2024-06-10
Form 8-K
ID: 0001517022-24-000057
2024-05-09
Form 10-Q
ID: 0001628280-24-021945
2024-05-09
Form 8-K
ID: 0001517022-24-000050
2024-04-23
Form 8-K
ID: 0001517022-24-000035